Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease

Journal: Nature Medicine

Published: 2019-01-21

DOI: 10.1038/s41591-018-0304-3

Affiliations: 26

Authors: 31

Go to article
Institutions FC
DZNE Site Tübingen, Germany 0.15
Department of Neurology, WUSTL, United States of America (USA) 0.09
Department of Radiology, WUSTL, United States of America (USA) 0.09
Division of Biostatistics, WUSTL, United States of America (USA) 0.09
Department of Biomedicine Basel, Switzerland 0.06
Department of Cellular Neurology, Uni Tübingen, Germany 0.05
Department of Psychiatry and Psychotherapy, Uni Tübingen, Germany 0.05
Department of Neurology, MGH, United States of America (USA) 0.03
USC Department of Neurology, United States of America (USA) 0.03
Brown Alpert Medical School (AMS), Brown University, United States of America (USA) 0.03
Mayo Clinic Department of Neurology, United States of America (USA) 0.03
Nash Family Department of Neuroscience, ISMMS, United States of America (USA) 0.03
DZNE Site Munich, Germany 0.03
Department of Neurology, LMU, Germany 0.03
Department of Biomedical Sciences, Macquarie University, Australia 0.02
School of Medical Sciences, ECU, Australia 0.02
School of Medical Sciences (SoMS), UNSW, Australia 0.02
UCL Dementia Research Centre (DRC), United Kingdom (UK) 0.02
UCL Department of Neurodegeneration, United Kingdom (UK) 0.02
The University of Melbourne (UniMelb), Australia 0.02
Florey Institute of Neuroscience and Mental Health, Australia 0.02
Indiana Alzheimer Disease Center, IUPUI, United States of America (USA) 0.02
Department of Pathology and Laboratory Medicine, IUPUI, United States of America (USA) 0.02
Taub Institute for Research on Alzheimer's Disease and the Aging Brain, CU, United States of America (USA) 0.02
Department of Neurology, CU, United States of America (USA) 0.02
Neuroscience Research Australia (NeuRA), Australia 0.02

Return